SCHEMBL16135265

SCHEMBL16135265

O=C(C(=O)N1CCCC(Cc2ccccc2)C1)c1c[nH]c2c(-n3ccnn3)ncc(F)c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 7/20 0.41
GABRG2 P18507 7/20 0.41
GABRB3 P28472 7/20 0.41
GABRA3 P34903 7/20 0.41
GABRA2 P47869 7/20 0.41
GABRB2 P47870 7/20 0.41
CYP3A4 P08684 2/20 0.37
CYP2D6 P10635 3/20 0.37
CYP2C9 P11712 2/20 0.37
CYP2C19 P33261 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C8 P10632 1/20 0.37
CYP2B6 P20813 1/20 0.37
KCNH2 Q12809 1/20 0.37
HSD11B1 P28845 1/20 0.36
CCR3 P51677 2/20 0.35
TACR3 P29371 2/20 0.35
TACR1 P25103 1/20 0.35
MAPK14 Q16539 1/20 0.34
FAAH O00519 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16942994 0.91 CYP2C9 (0.42) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL16135264 0.88 CYP3A4 (0.39) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL16135261 0.85 CYP3A4 (0.40) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL16135243 0.84 CYP3A4 (0.40) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL16142685 0.83 CYP3A4 (0.41) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL14754196 0.82 CYP3A4 (0.37) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL16142763 0.82 CYP3A4 (0.40) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL16135262 0.82 BTK (0.39) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2
SCHEMBL16135269 0.81 PROKR1 (0.41)
SCHEMBL16135244 0.81 CYP3A4 (0.40) CYP3A4CYP2D6CYP2C9CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2978763-B1 2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS VIIV HEALTHCARE UK (NO 5) LTD (GB) 2018-03-07 EP disclosed
US-9586957-B2 2-keto amide derivatives as HIV attachment inhibitors VIIV Healthcare UK (No.5) Limited (GB) 2017-03-07 US disclosed
US-9586957-B2 2-keto amide derivatives as HIV attachment inhibitors VIIV Healthcare UK (No.5) Limited (GB) 2017-03-07 US disclosed
WO-2014160692-A1 2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2014-10-02 WO disclosed